Proactive Investors - Run By Investors For Investors

Amphion enjoys improvement in equity markets

Amphion enjoys improvement in equity markets

Amphion Innovations (LON:AMP), the incubator for technology companies, gave a guardedly optimistic assessment of its prospects in the first half.

The planned listing of partner company Kromek, the scanners business, points to a favourable turn in the equity market and will give Amphion’s 13.3% stake an objective valuation.

It may also make it easier for its other fledglings to access capital to continue their development.

One of its firms, WellGen, has done this via the award of a phase-one SBIR grant by the National Institutes of Health.

The grant will help it progress the clinical investigation of its proprietary natural extracts in controlling type-two diabetes.

Amphion said it remains confident the DataTern business can generate “a substantial profit” from infringers of its intellectual property. That said the legal process has slowed.

The financials reveal the group generated revenues of US$264,638 during the six months to June 30 – in line with the final half of last year – and posted an operating loss of just over US$1mln. The net asset value as at the period-end was 12 cents (8p).

The statement did come with a cautionary statement on the group’s financial position as it said support for Amphion in the first half “has continued to be provided, for the most part, by loans from the directors and additional contributions from the management team”.

Why Invest In Amphion Innovations Plc? Read More Here

Register here to be notified of future AMP Company articles
View full AMP profile

Amphion Innovations Plc Timeline

February 07 2017
Big Picture
November 21 2016
September 08 2016

Related Articles

five people sat on chairs waiting for a job interview
September 27 2016
finnCap issued a bullish note on the background screening firm today and thinks the share price could add nearly 50% over the coming months
eSports player at a Gfinity event
eSports are tipped to generate more than £1bn a year in a global revenue by 2020, while audience numbers are set to go through the roof too
December 13 2016
Fourteen major car makers have been trialling the company’s unique eye and facial recognition tracking system.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.